Defibrillation thresholds are increased by right-sided implantation of totally transvenous implantable cardioverter defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 8, 1999, Pages 1186-1192

  Friedman, Paul A ^a   Rasmussen, Mary Jane ^a   Grice, Suellen ^a   Trusty, Jane ^a   Glikson, Michael ^b   Stanton, Marshall S ^a  

^a MAYO CLINIC   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Defibrillation; Defibrillation threshold; Implantable defibrillator

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; MALE; TREATMENT OUTCOME; VASCULAR ACCESS;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MIDDLE AGED; PROSTHESIS IMPLANTATION; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; SUBCLAVIAN VEIN; TREATMENT OUTCOME; VENA CAVA, SUPERIOR;

EID: 0032782613     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00599.x     Document Type: Article

References (21)

1. The Antiarrhythmics versus Implantable Defibrillators Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Circulation 1997; 95:777.
2. The Antiarrhythmics versus Implantable Defibrillators Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.
3. Stanton M, Hayes D, Munger T, et al. Consistent subcutaneous prepectoral implantation of a new implantable cardioverter defibrillator. Mayo Clin Proc 1994; 69:309-314.
4. Friedman P, Stanton M. The pacer-cardioverter-defibrillator: Function and clinical experience. J Cardiovasc Electrophysiol 1995; 6:68.
5. Bardy G, Hofer B, Johnson G, et al. Implantable transvenous cardioverter-defibrillators. Circulation 1993; 87:1152-1168.
6. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335:1933-1940.
7. Underwood RD, Sra J, Akhtar M. Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction. Clin Cardiol 1997; 20:753-758.
8. Friedman P, Grice S, Espinosa R, et al. Defibrillation thresholds are significantly increased by a right-sided approach to totally transvenous implantable defibrillator system placement, (abstract) J Am Coll Cardiol 1997; 29(Suppl. A):472A.
9. Epstein A, Kay G, Plumb V, et al. Elevated defibrillation threshold when right-sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. J Cardiovasc Electrophysiol 1995; 6:979-986.
10. Dixon E, Tang A, Wolf P, et al. Improved defibrillation thresholds with large contoured epicardial electrodes and biphasic waveforms. Circulation 1987; 76:1176-1184.
11. Ideker R, Wolf P, Alferness C, et al. Current concepts for selecting the location, size and shape of defibrillation electrodes. PACE 1991; 14: 227-239.
12. Ideker R, Tang A, Frazier D, et al. Ventricular defibrillation: Basic concepts. In N El Sherif, P Samet (ed.): Cardiac Pacing Electrophysiology. WB Saunders Co., Philidelphia PA, 1991.
13. Saksena S, DeGroot P, Krol R, et al. Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location. Circulation 1993; 88:2655-2660.
14. Hillsley R, Wharton J, Cates A, et al. Why do some patients have high defibrillation thresholds at defibrillator implantation? Answers from basic research. PACE 1994; 17:222-239.
15. Markewitz A, Kaulbach H, Mattke S, et al. The left subclavian vein as an alternative site for implantation of the second defibrillation lead. PACE 1995; 18(Pt. I):401-405.
16. Bardy G, Dolack L, Kudenchuk P, et al. Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode. Circulation 1994; 89:1090-1093.
17. Heil J, Lin Y, Derfus D, et al. Impact of ICD electrode position on transvenous defibrillation thresholds. PACE 1995; 18(Pt. II):873.
18. Kudenchuck P, Bardy G, Dolack G, et al. Efficacy of a single lead unipolar transvenous defibrillator compared with a system employing an additional coronary sinus electrode. Circulation 1994; 89:2641-2644.
19. Natale A, Sra J, Geiger M, et al. Right side unipolar single lead defibrillation system. PACE 1997; 20(Pt. I):1910-1912.
20. Min X, Mehra R. Right sided pectoral can with additional superior vena cava electrode to RV ventricular defibrillation by finite element analysis, (abstract) PACE 1995; 18(Pt. H):886.
21. Min X, Wang L, Hill M, et al. Computer modeling of active can to RV and SVC to RV defibrillation electrode systems in the human thorax model, (abstract) PACE 1994; 17(Pt. II):756.